This document discusses several sexually transmitted diseases including gonorrhea, syphilis, and chlamydia. It provides definitions, signs and symptoms, methods of diagnosis, and treatment recommendations for each disease as outlined by health organizations like the CDC. Key points include that gonorrhea is caused by Neisseria gonorrhoeae bacteria, syphilis by Treponema pallidum, and chlamydia by Chlamydia trachomatis. Symptoms and signs vary for each disease and stage. Diagnosis involves tests of genital secretions. Recommended antibiotic treatments are also provided.
This document discusses several sexually transmitted diseases including gonorrhea, syphilis, and chlamydia. It provides definitions, signs and symptoms, methods of diagnosis, and treatment recommendations for each disease as outlined by health organizations like the CDC. Key points include that gonorrhea is caused by Neisseria gonorrhoeae bacteria, syphilis by Treponema pallidum, and chlamydia by Chlamydia trachomatis. Symptoms and signs vary for each disease and stage. Diagnosis involves tests of genital secretions. Recommended antibiotic treatments are also provided.
This document discusses several sexually transmitted diseases including gonorrhea, syphilis, and chlamydia. It provides definitions, signs and symptoms, methods of diagnosis, and treatment recommendations for each disease as outlined by health organizations like the CDC. Key points include that gonorrhea is caused by Neisseria gonorrhoeae bacteria, syphilis by Treponema pallidum, and chlamydia by Chlamydia trachomatis. Symptoms and signs vary for each disease and stage. Diagnosis involves tests of genital secretions. Recommended antibiotic treatments are also provided.
Clinical Pharmacy DEFINITION • The spectrum of STDs includes: – Gonorrhea – Syphilis – C. trachomatis • The most current information on epidemiology, diagnosis, & ttt of STDs provided by the Centers for Disease Control & Prevention (CDC) can be found at http://www.cdc.gov.
Dr. Salah Wageehuddein, Clinical Pharmacy
GONORRHEA
Dr. Salah Wageehuddein, Clinical Pharmacy
GONORRHEA • Neisseria gonorrhoeae is a gram-negative diplococcus estimated to cause up to 600,000 infections per year in the United States. • Humans are the only known host of this intracellular parasite.
Dr. Salah Wageehuddein, Clinical Pharmacy
GONORRHEA • CLINICAL PRESENTATION • Infected individuals may be symptomatic or asymptomatic, have complicated or uncomplicated infections.
Dr. Salah Wageehuddein, Clinical Pharmacy
GONORRHEA • DIAGNOSIS – Gram-stained smears – Culture (the most reliable method) – Enzymes, antigens, DNA, or lipopolysaccharide) in clinical specimens.
Dr. Salah Wageehuddein, Clinical Pharmacy
GONORRHEA • Treatment • All currently recommended regimens are single-dose ttts with various oral or parenteral cephalosporins & fluoroquinolones
Dr. Salah Wageehuddein, Clinical Pharmacy
GONORRHEA • Ceftriaxone is the only parenteral agent recommended by the CDC as a 1st line agent for ttt of gonorrhea. • Coexisting chlamydial infection, constitutes the major cause of postgonococcal urethritis, cervicitis, in patients tted for gonorrhea. • As a result, concomitant ttt with doxycycline or azithromycin is recommended in all patients tted for gonorrhea. • A single dose of azithromycin (2 g) is highly effective against chlamydia. Dr. Salah Wageehuddein, Clinical Pharmacy GONORRHEA • Pregnant women infected with N. gonorrhoeae should be tted with either a cephalosporin or spectinomycin, because fluoroquinolones are C/Ied. • Azithromycin or amoxicillin is the preferred ttt for presumed Chlamydia trachomatis infection.
Dr. Salah Wageehuddein, Clinical Pharmacy
GONORRHEA • ttt of gonorrhea during pregnancy is essential to prevent complication on the neonate eyes. • Tetracycline (1%) ophthalmic oint or erythromycin (0.5%) ophthalmic oint be instilled in each conjunctival sac immediately postpartum to prevent ophthalmia neonatorum.
Dr. Salah Wageehuddein, Clinical Pharmacy
GONORRHEA
Dr. Salah Wageehuddein, Clinical Pharmacy
GONORRHEA
Dr. Salah Wageehuddein, Clinical Pharmacy
Dr. Salah Wageehuddein, Clinical Pharmacy SYPHILIS
Dr. Salah Wageehuddein, Clinical Pharmacy
SYPHILIS • The causative organism of syphilis is Treponema pallidum , a spirochete. • Also syphilis can be acquired by nonsexual personal contact e.g. blood transfusion.
Dr. Salah Wageehuddein, Clinical Pharmacy
SYPHILIS • Primary Syphilis • Characterized by the appearance of a chancre on cutaneous or mucocutaneous tissue & persist only for 1-8 w before spontaneously disappearing.
Dr. Salah Wageehuddein, Clinical Pharmacy
SYPHILIS • Secondary Syphilis • Characterized by a variety of mucocutaneous eruptions, resulting from widespread hematogenous & lymphatic spread of T. pallidum. • Signs & symptoms of secondary syphilis disappear in 4-10 w however, in untted patients, lesions may recur at any time within 4 years.
Dr. Salah Wageehuddein, Clinical Pharmacy
SYPHILIS • Latent Syphilis • Persons with a +ve serologic test for syphilis but with no other evidence of disease have latent syphilis. • Most untted patients with latent syphilis have no further sequelae; however, approximately 25-30% progress to either neurosyphilis or late syphilis with clinical manifestations other than neurosyphilis.
Dr. Salah Wageehuddein, Clinical Pharmacy
SYPHILIS • Tertiary Syphilis & Neurosyphilis • 40% of patients with primary or secondary syphilis exhibit CNS infection.
Dr. Salah Wageehuddein, Clinical Pharmacy
SYPHILIS • DIAGNOSIS • Because T. pallidum is difficult to culture in vitro, diagnosis is based primarily on dark-field or direct fluorescent antibody microscopic examination of serous material from a suspected syphilitic lesion or on results from serologic testing. • Serologic tests are the mainstay.
Dr. Salah Wageehuddein, Clinical Pharmacy
SYPHILIS • Treatment • See table 46-6 for ttt recommendations. • Parenteral penicillin G is the ttt of choice for all stages of syphilis. • Benzathine penicillin G is the only penicillin effective for single-dose therapy. • Patients with abnormal cerebrospinal fluid findings should be tted as having neurosyphilis. Dr. Salah Wageehuddein, Clinical Pharmacy SYPHILIS • Pregnant patients: • Penicillin is the ttt of choice at the dosage recommended. • To ensure ttt success & prevent transmission to the fetus, some experts advocate an additional IM dose of benzathine penicillin G, 2.4 million units, 1 week after completion of the recommended regimen.
Dr. Salah Wageehuddein, Clinical Pharmacy
SYPHILIS • Jarisch-Herxheimer reaction: • It may be appear in majority of patients tted for primary & secondary syphilis after ttt. • Characterized by flu-like symptoms such as transient headache, fever, chills, malaise, arthralgia, myalgia, tachypnea, peripheral vasodilation, & aggravation of syphilitic lesions. • This should not be confused with penicillin allergy. • It need symptomatic management with analgesics, antipyretics, & rest. Dr. Salah Wageehuddein, Clinical Pharmacy SYPHILIS • Serology tests should be performed at 6 & 12 ms in all patients tted for primary & secondary syphilis & at 6, 12, & 24 ms for early & late latent disease. • For women tted during pregnancy, monthly, serology tests are recommended in those at high risk of reinfection.
Dr. Salah Wageehuddein, Clinical Pharmacy
CHLAMYDIA
Dr. Salah Wageehuddein, Clinical Pharmacy
CHLAMYDIA • C. trachomatis is an obligate intracellular parasite that has some similarities to viruses & bacteria.
Dr. Salah Wageehuddein, Clinical Pharmacy
CHLAMYDIA • CLINICAL PRESENTATION • They are more frequently asymptomatic, & when present, symptoms tend to be less noticeable.
Dr. Salah Wageehuddein, Clinical Pharmacy
CHLAMYDIA • Chlamydia may be transmitted to an infant during contact with infected cervicovaginal secretions. • Nearly 2/3 of infants acquire chlamydial infection after endocervical exposure, with the primary morbidity associated of the infant’s eyes, nasopharynx, rectum, or vagina.
Dr. Salah Wageehuddein, Clinical Pharmacy
CHLAMYDIA • DIAGNOSIS • Culture of endocervical or urethral epithelial cell scrapings is the most specific method. • For rapid identification in genital secretions (30 min): – direct fluorescent antibody test. – the enzyme immunoassay. – DNA test.
Dr. Salah Wageehuddein, Clinical Pharmacy
CHLAMYDIA • Treatment • Single-dose azithromycin & 7-day doxycycline are the agents of choice.
Dr. Salah Wageehuddein, Clinical Pharmacy
CHLAMYDIA
Dr. Salah Wageehuddein, Clinical Pharmacy
CHLAMYDIA • Prophylaxis of ophthalmia neonatorum: • Erythromycin (0.5%) or tetracycline (1%) ophthalmic oint in lieu of silver nitrate. • Although silver nitrate & antibiotic oint are effective against gonococcal ophthalmia neonatorum, silver nitrate is not effective for chlamydial disease & may cause a chemical conjunctivitis.
Dr. Salah Wageehuddein, Clinical Pharmacy
CHLAMYDIA • ttt of chlamydial infections with the recommended regimens is highly effective; therefore, post-ttt cultures are not routinely recommended. • Infants with pneumonitis should receive follow-up testing, because erythromycin is only 80% effective.